How pharmacogenomics might help addiction treatment

Naltrexone Molecule How pharmacogenomics might help addiction treatment 20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments? By Kerry Grens ARTICLE EXTRAS 1 In 2003 David Oslin and Charles O'Brien at the University of Pennsylvania's Center for Addiction Treatment and their colleagues reported an association between this SNP and how well

kerry grens
Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at...

View full profile.


Learn about our editorial policies.

May 1, 2007

Naltrexone Molecule

How pharmacogenomics might help addiction treatment

20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments?
By Kerry Grens



Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?